Lack of association between CX3CR1 V249I and T280M polymorphisms and risk of Parkinson's disease in a Greek population - PubMed (original) (raw)
Lack of association between CX3CR1 V249I and T280M polymorphisms and risk of Parkinson's disease in a Greek population
Kallirhoe Kalinderi et al. Genet Test Mol Biomarkers. 2012 Aug.
Abstract
Mechanisms that mediate inflammatory responses may be crucial in Parkinson's disease (PD) pathogenesis. In the brain, the chemokine receptor CX3CR1 is exclusively expressed in microglia, selectively mediating microglia-neuron interaction in response to its ligand, the chemokine fractalkine. Two functional single nucleotide polymorphisms, V249I and T280M, in the coding sequence of the CX3CR1 receptor have been found to alter ligand-receptor affinity. The aim of this study was to investigate the genetic role of CX3CR1 in sporadic PD. We examined the V249I and T280M CX3CR1 polymorphisms in a case-control study of 176 sporadic PD patients and 115 controls. Polymerase chain reaction-restriction fragment length polymorphism analysis was performed for the detection of the studied CX3CR1 genotypes. This is the first study that tests CX3CR1 gene polymorphisms in patients with PD. We found no differences in genotype or haplotype frequencies between PD patients and controls, suggesting that CX3CR1 V249I and T280M polymorphisms do not increase susceptibility to PD. Additional studies should further investigate the CX3CL1-CX3CR1 axis in PD.
Similar articles
- Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.
Brand S, Hofbauer K, Dambacher J, Schnitzler F, Staudinger T, Pfennig S, Seiderer J, Tillack C, Konrad A, Göke B, Ochsenkühn T, Lohse P. Brand S, et al. Am J Gastroenterol. 2006 Jan;101(1):99-106. doi: 10.1111/j.1572-0241.2005.00361.x. Am J Gastroenterol. 2006. PMID: 16405540 - The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease.
Sabate JM, Ameziane N, Lamoril J, Jouet P, Farmachidi JP, Soulé JC, Harnois F, Sobhani I, Jian R, Deybach JC, de Prost D, Coffin B. Sabate JM, et al. Eur J Gastroenterol Hepatol. 2008 Aug;20(8):748-55. doi: 10.1097/MEG.0b013e3282f824c9. Eur J Gastroenterol Hepatol. 2008. PMID: 18617779 - Association of chemokine receptor CX3CR1 V249I and T280M polymorphisms with chronic kidney disease.
Yadav AK, Kumar V, Jha V. Yadav AK, et al. Indian J Nephrol. 2016 Jul-Aug;26(4):275-9. doi: 10.4103/0971-4065.163426. Indian J Nephrol. 2016. PMID: 27512300 Free PMC article. - Associations Between the T280M and V249I SNPs in CX3CR1 and the Risk of Age-Related Macular Degeneration.
Zhang R, Wang LY, Wang YF, Wu CR, Lei CL, Wang MX, Ma L. Zhang R, et al. Invest Ophthalmol Vis Sci. 2015 Aug;56(9):5590-8. doi: 10.1167/iovs.15-16830. Invest Ophthalmol Vis Sci. 2015. PMID: 26305531 Review. - Association of CX3CR1 (V249I and T280M) polymorphisms with age-related macular degeneration: a meta-analysis.
Li D, Peng X, Sun H. Li D, et al. Can J Ophthalmol. 2015 Dec;50(6):451-60. doi: 10.1016/j.jcjo.2015.08.010. Can J Ophthalmol. 2015. PMID: 26651305 Review.
Cited by
- Role of α-synuclein in inducing innate and adaptive immunity in Parkinson disease.
Allen Reish HE, Standaert DG. Allen Reish HE, et al. J Parkinsons Dis. 2015;5(1):1-19. doi: 10.3233/JPD-140491. J Parkinsons Dis. 2015. PMID: 25588354 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous